Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1191388018 | Daclizumab 25mg/5mL infusion concentrate (product) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
| 2164777019 | Daclizumab 25mg/5 mL solution | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| 466806012 | Daclizumab 25mg/5mL infusion concentrate | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Daclizumab 25mg/5mL infusion concentrate | Is a | Daclizumab-containing product | false | Inferred relationship | Some | ||
| Daclizumab 25mg/5mL infusion concentrate | Is a | Daclizumab-containing product | false | Inferred relationship | Some | ||
| Daclizumab 25mg/5mL infusion concentrate | Has active ingredient | Monoclonal antibody | false | Inferred relationship | Some | ||
| Daclizumab 25mg/5mL infusion concentrate | Has active ingredient | Daclizumab | false | Inferred relationship | Some | ||
| Daclizumab 25mg/5mL infusion concentrate | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
| Daclizumab 25mg/5mL infusion concentrate | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
| Daclizumab 25mg/5mL infusion concentrate | Has manufactured dose form | Infusion concentrate | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
Description inactivation indicator reference set
REPLACED BY association reference set
FHIR